Discussing PsA: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population
Aug 12, 2024
38:13
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Join Professors Peter Nash, Philip Mease, Frank Behrens, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, including the long-term safety of ixekizumab as well as bimekizumab treatment in a TNFi-IR population.